Leszek Paczek

Author PubWeight™ 33.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. Transplantation 2004 1.44
2 Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs. Nephrol Dial Transplant 2009 1.18
3 Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease? Nephrol Dial Transplant 2010 1.08
4 Urinary levels of interleukin-6 and interleukin-8 in children with urinary tract infections to age 2. Med Sci Monit 2004 0.96
5 Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study. Transplantation 2003 0.94
6 Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit 2009 0.92
7 Lack of relationship between interleukin-6 and CRP levels in healthy male athletes. Immunol Lett 2005 0.90
8 Urine proteome of autosomal dominant polycystic kidney disease patients. Clin Proteomics 2012 0.89
9 Efficacy of rapamycin in patient with juvenile rheumatoid arthritis. Transpl Int 2005 0.88
10 A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. Transplantation 2003 0.87
11 High-throughput sequencing identification of novel and conserved miRNAs in the Brassica oleracea leaves. BMC Genomics 2013 0.87
12 Infections caused by clostridium difficile in kidney or liver graft recipients. Ann Transplant 2005 0.85
13 Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation 2003 0.84
14 Gene expression profile as a prognostic factor in high-grade gliomas. Int J Oncol 2007 0.84
15 The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation. Ann Transplant 2003 0.84
16 Generic formulation of Cyclosporine A, Equoral®, in de novo kidney transplant recipients: five-year follow-up. Ann Transplant 2011 0.84
17 Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci 2013 0.82
18 The early and long term function and survival of kidney allografts stored before transplantation by hypothermic pulsatile perfusion. A prospective randomized study. Ann Transplant 2009 0.81
19 Bacteriological urinalysis in patients after renal transplantation. Pol J Microbiol 2005 0.81
20 Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor. Transpl Immunol 2008 0.80
21 Proteins contribute insignificantly to the intrinsic buffering capacity of yeast cytoplasm. Biochem Biophys Res Commun 2012 0.80
22 [Cytokines in noninvasive diagnostics of diabetic nephropathy progression]. Pol Merkur Lekarski 2002 0.79
23 Results of liver transplantation in the Department of General, Transplant and Liver Surgery at the Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection. Przegl Epidemiol 2013 0.79
24 Influence of preservation method on histopathological lesions of kidney allografts. Ann Transplant 2009 0.79
25 Autosomal dominant polycystic kidney disease and transplantation. Ann Transplant 2009 0.78
26 Myogenic stem cells. Folia Histochem Cytobiol 2008 0.78
27 Urine cytokines profile in renal transplant patients with asymptomatic bacteriuria. Transplantation 2006 0.78
28 Hypophosphatemia and sudden infant death syndrome (SIDS)--is ATP the link? Ups J Med Sci 2013 0.78
29 The comparison of treatment results of type 1 diabetes mellitus complicated by end-stage diabetic nephropathy in patients undergoing simultaneous pancreas and pre-emptive kidney transplantation (SPPkTx) and patients enrolled into the dialysis program--a cohort study. Ann Transplant 2005 0.77
30 [The course of hepatitis C infection after liver transplantation]. Pol Merkur Lekarski 2005 0.77
31 [The aging of the immune system]. Przegl Lek 2003 0.77
32 Tonsil enlargement after liver transplantation in adults--reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative disease. Liver Transpl 2007 0.77
33 [The role of T helper lymphocytes population: Th1, Th2, and Th3 in human immune response]. Pol Arch Med Wewn 2002 0.77
34 [Liver regeneration]. Pol Merkur Lekarski 2005 0.77
35 [Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma]. Pol Arch Med Wewn 2002 0.76
36 Results of liver transplantation for hepatocellular cancer. Ann Transplant 2007 0.76
37 The efficacy and safety of ciclosporin (Equoral®) capsules after renal transplantation: A multicentre, open-label, phase IV clinical trial. Ann Transplant 2010 0.76
38 Sirolimus-associated hepatotoxicity in the kidney graft recipient. Transpl Int 2005 0.76
39 Ezetimibe in sirolimus-associated hyperlipidemia: to add or not to add to statins? Ann Transplant 2011 0.76
40 Antiviral therapy preceding liver transplantation in HCV cirrhosis--still too many doubts. J Hepatol 2009 0.75
41 Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS. Eur J Haematol 2014 0.75
42 [Liver fibrosis and cirrhosis--selected cytokines, growth factors and proteins. Part II]. Przegl Lek 2011 0.75
43 Mesenchymal Stem Cells from Human Amniotic Membrane and Umbilical Cord Can Diminish Immunological Response in an in vitro Allograft Model. Gynecol Obstet Invest 2016 0.75
44 [Cholangiocarcinoma (CHCC). The role of liver transplantation in treatment of CHCC]. Pol Arch Med Wewn 2004 0.75
45 [The role of inflammatory factors in risk assessment of renal insufficiency in diabetes mellitus]. Pol Arch Med Wewn 2005 0.75
46 C4d-positive renal transplants: single-center clinical outcomes. Clin Transpl 2006 0.75
47 [Myogenic stem cells--the new material for periurethral injections in the treatment of urinary incontinence]. Przegl Lek 2008 0.75
48 Organ transplantation in Poland. Transplant Proc 2002 0.75
49 Quality of life after liver transplantation--preliminary report. Ann Transplant 2008 0.75
50 [Treatment of diabetes mellitus in patients after renal transplantation]. Pol Merkur Lekarski 2002 0.75
51 Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin. Ann Transplant 2007 0.75
52 The role of the kidney in the systemic elimination of interleukin 6, platelet-derived growth factor and transforming growth factor beta. Cytokine 2012 0.75
53 [Noninvasive monitoring of chronic glomerulonephritides progression]. Pol Merkur Lekarski 2002 0.75
54 Living donor organ donation. Safety and limits. Consensus on living donation in Poland. Ann Transplant 2002 0.75
55 [Technical progress in liver transplantation]. Przegl Epidemiol 2005 0.75
56 [Correlation between the content of transforming growth factor-beta 1, interleukin-1 beta and collagenase activity in proximal femur bone samples obtained from patients with femoral neck fracture]. Chir Narzadow Ruchu Ortop Pol 2005 0.75
57 Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients--long term results. Ann Transplant 2008 0.75
58 Secondary kidney transplantation in a patient 16 years after simultaneous pancreas and kidney transplantation--a case report. Ann Transplant 2006 0.75
59 Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft--a single-center analysis of 1112 cases. Transpl Int 2003 0.75
60 [Stem cell transplantation: new method of treatment]. Pol Arch Med Wewn 2002 0.75
61 [New immune suppressants: topical immunomodulatory agents]. Przegl Lek 2002 0.75
62 [Liver fibrosis and cirrhosis--causes. Part I]. Przegl Lek 2011 0.75
63 Exercise differentially regulates renalase expression in skeletal muscle and kidney. Tohoku J Exp Med 2013 0.75
64 Successful outcome of transplant of kidneys recovered from a brain-dead liver transplant recipient: case report. Prog Transplant 2012 0.75
65 [Blockers of receptors for advanced glycation end products--new therapeutic possibilities]. Pol Arch Med Wewn 2003 0.75
66 [Cellular cardiomyoplasty in the treatment of myocardial infarct and heart failure]. Pol Arch Med Wewn 2004 0.75
67 [Hemochromatosis. Indication to liver transplantation and recurrence of disease after transplantation]. Pol Arch Med Wewn 2004 0.75
68 [Hypertension in liver transplant recipients]. Przegl Lek 2011 0.75
69 [Ocular manifestations in bone marrow transplantation--case report]. Klin Oczna 2005 0.75
70 [Effect of immunosuppressive treatment on diurnal profile of blood pressure]. Pol Merkur Lekarski 2002 0.75
71 [Living kidney donation--clinical consequences]. Pol Arch Med Wewn 2004 0.75
72 [Expression of mRNA for growth factors and cytokines in the renal artery wall of chronically rejected renal allograft]. Pol Merkur Lekarski 2002 0.75
73 Assessment of cadaveric livers discarded from transplantation. A correlation between clinical and histological parameters. Ann Transplant 2007 0.75
74 Primary T-cell lymphoma of the calcaneus in the kidney transplant recipient. Nephrol Dial Transplant 2007 0.75
75 [Liver transplantation for hepatocellular carcinoma]. Pol Arch Med Wewn 2003 0.75
76 [Liver transplantation in Budd-Chiari syndrome]. Pol Arch Med Wewn 2003 0.75
77 A retrospective study of steroid elimination in simultaneous pancreas and preemptive kidney transplant (Sppre-Ktx) recipients. Ann Transplant 2006 0.75
78 Evaluation of chronic HCV infection in transplanted livers using a modified histological activity index. Ann Transplant 2011 0.75
79 Professor Tadeusz Orlowski--in memory of a pioneer in European nephrology and transplantation. Kidney Blood Press Res 2009 0.75
80 [Current status of liver transplantation]. Przegl Epidemiol 2005 0.75
81 [Regulatory mechanisms and the influence of immunosuppressive drugs on liver regeneration after partial hepatectomy]. Pol Arch Med Wewn 2003 0.75